Related Experiment Videos
EBV-transformed lymphoblastoid cell lines down-regulate EBNA in parallel with secretory differentiation
International Journal of Cancer
|March 15, 1987
Summary
Lymphoblastoid cell lines (LCLs) show two cell types: proliferating, Epstein-Barr virus nuclear antigen (EBNA)-positive, immunoglobulin-negative cells and non-proliferating, EBNA-negative, immunoglobulin-positive cells, suggesting ongoing B-cell maturation.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Lymphoblastoid cell lines (LCLs) are crucial tools for studying B-cell biology and Epstein-Barr virus (EBV) interactions.
- Understanding the heterogeneity within LCLs is key to deciphering B-cell differentiation pathways.
Purpose of the Study:
- To investigate the expression of cytoplasmic immunoglobulin (cIg), Epstein-Barr virus-determined nuclear antigen (EBNA), and DNA synthesis in LCLs.
- To characterize the subpopulations within LCLs and explore potential B-cell maturation processes.
Main Methods:
- Analysis of four monoclonal and one polyclonal LCLs.
- Assessment of cytoplasmic immunoglobulin (cIg) expression.
- Detection of Epstein-Barr virus-determined nuclear antigen (EBNA).
- Measurement of DNA synthesis.
Main Results:
- Each LCL comprised two distinct subpopulations with minimal overlap.
- The majority population was proliferating, EBNA-positive, and cIg-negative.
- A minority population was non-proliferating, EBNA-negative, and contained abundant cIg.
Conclusions:
- LCLs exhibit continuous B-cell maturation, characterized by distinct subpopulations.
- Down-regulation of EBNA correlates with B-cell differentiation, raising questions about the compatibility of EBNA synthesis with maturation.
- Epigenetic regulation or viral genome suppression may influence B-cell differentiation within LCLs.